Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
19 Jul 2024 07:45 CEST |
BOLIDEN AB | Boliden Q2 2024: Results affected by insurance income and decision to reopen Tara | 55102000 General Mining | Half yearly financial reports and audit reports/limited reviews |
19 Jul 2024 07:30 CEST |
Pareto Bank ASA | Pareto Bank ASA Delårsrapport 2. kvartal 2024 | 30101010 Banks | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
19 Jul 2024 07:30 CEST |
DANSKE BANK A/S | Strong business performance and positive outlook underpinned by robust customer activity and slightly improved macroeconomic environment Net profit of DKK 11.5 billion for the first half of 2024 | 30101010 Banks | Half yearly financial reports and audit reports/limited reviews |
19 Jul 2024 07:30 CEST |
NICOX S.A. | Nicox : Participation aux prochaines conférences | 20103015 Pharmaceuticals | Meetings / events |
19 Jul 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
19 Jul 2024 07:30 CEST |
MAUREL ET PROM | Maurel & Prom : Evolution de la gouvernance | 60101010 Oil: Crude Producers | Journal / appointments |
19 Jul 2024 07:30 CEST |
AXWAY SOFTWARE | Axway Software:Half-Year Performance In Line With Annual Targets | 10101015 Software | Sales |
19 Jul 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
19 Jul 2024 07:30 CEST |
NICOX S.A. | Nicox announces attendance at upcoming conferences | 20103015 Pharmaceuticals | Meetings / events |
19 Jul 2024 07:30 CEST |
MAUREL ET PROM | Maurel & Prom: Changes in Governance | 60101010 Oil: Crude Producers | Journal / appointments |
19 Jul 2024 07:30 CEST |
AXWAY SOFTWARE | Axway Software :Performance semestrielle conforme aux objectifs annuels | 10101015 Software | Sales |
19 Jul 2024 07:29 CEST |
DANSKE BANK A/S | Danske Bank will pay out dividend for the first half-year of 2024, intends to distribute released capital from exit of Norwegian personal customer business and the remaining 2024 net profit | 30101010 Banks | Inside information |
19 Jul 2024 07:00 CEST |
Tomra Systems ASA | TOMRA: 2Q 2024 - Continued strong momentum in Collection; Gross margin improvements across all divisions | 50204000 Machinery: Industrial | Half yearly financial reports and audit reports/limited reviews |
19 Jul 2024 07:00 CEST |
EMEIS | emeis : Bilan semestriel (S1 2024) du contrat de liquidité conclu avec Natixis ODDO BHF | 20101010 Health Care Facilities | Other subject |
19 Jul 2024 07:00 CEST |
ORANGE BELGIUM | Solide omzetgroei en sterke EBITDAaL performantie - EBITDAaL vooruitzichten verbeterd | 15102015 Telecommunications Services | Other subject |
19 Jul 2024 07:00 CEST |
ORANGE BELGIUM | Solid revenue growth and strong EBITDAaL performance - EBITDAaL guidance improved | 15102015 Telecommunications Services | Other subject |
19 Jul 2024 07:00 CEST |
FORSEE POWER | Bilan semestriel du contrat de liquidité de la société FORSEE POWER | 50202010 Electrical Components | Other subject |
19 Jul 2024 07:00 CEST |
FORSEE POWER | Half-Year Liquidity Contract Statement for FORSEE POWER | 50202010 Electrical Components | Other subject |
19 Jul 2024 07:00 CEST |
ORANGE BELGIUM | Croissance soutenue du chiffre d'affaires et forte amélioration de l’EBITDAaL - Perspectives de l’EBITDAaL améliorées | 15102015 Telecommunications Services | Other subject |
19 Jul 2024 07:00 CEST |
EMEIS | emeis: Half-year review (H1 2024) of the liquidity agreement entered into with Natixis ODDO BHF | 20101010 Health Care Facilities | Other subject |
18 Jul 2024 23:00 CEST |
CASINO GUICHARD | Casino Group Communication | 45201010 Food Retailers and Wholesalers | New |
18 Jul 2024 23:00 CEST |
CASINO GUICHARD | Communication du groupe Casino | 45201010 Food Retailers and Wholesalers | New |
18 Jul 2024 22:50 CEST |
KMC Properties ASA | KMC Properties ASA – Dividend Shares | 35101010 Real Estate Holding and Development | Additional regulated information required to be disclosed under the laws of a Member State |
18 Jul 2024 22:41 CEST |
ECIT AS B-AKSJER | Conversion of share class | 50205020 Professional Business Support Services | Total number of voting rights and capital |
18 Jul 2024 22:09 CEST |
SKANDIA GREENPOWER AS | Meldepliktig handel for primærinnsider | 65101010 Alternative Electricity | Meldepliktig handel for primærinnsidere |
18 Jul 2024 21:24 CEST |
FARMINVESTE | Farminveste-SGPS, S.A. informa sobre Deliberações da Assembleia Geral Anual | 20101030 Health Care: Misc. | General meeting / Board Meeting |
18 Jul 2024 21:24 CEST |
FARMINVESTE | Farminveste-SGPS, S.A. informa sobre o calendário financeiro para 2024 | 20101030 Health Care: Misc. | Other subject |
18 Jul 2024 19:31 CEST |
BE Semiconductor Industries N.V. | BE Semiconductor Industries N.V. Announces 2024 Second Quarter Conference Call and Webcast Details | 10102010 Semiconductors | Other subject |
18 Jul 2024 19:05 CEST |
IKONISYS | Ikonisys Completed a Capital Increase Through a Private Placement | 20102010 Medical Equipment | Share introduction and issues |
18 Jul 2024 19:05 CEST |
IKONISYS | Ikonisys a finalisé une augmentation de capital par le biais d'un placement privé | 20102010 Medical Equipment | Share introduction and issues |
18 Jul 2024 18:45 CEST |
WALLIX | Sustained hypergrowth in recurring business in H1 2024 | 10101015 Software | Legal |
18 Jul 2024 18:45 CEST |
WALLIX | Hyper croissance maintenue des revenus récurrents au 1er semestre 2024 | 10101015 Software | Legal |
18 Jul 2024 18:44 CEST |
INTEGRAGEN | IntegraGen : Chiffre d’affaires de 4,5 M€ au premier semestre 2024, en hausse de 6% sur le périmètre hors SeqOIA et position de trésorerie de 2,8 M€ | 20103010 Biotechnology | Sales |
18 Jul 2024 18:44 CEST |
INTEGRAGEN | IntegraGen: First-Half 2024 Sales of €4.5m, up 6% on the Scope Excluding SeqOIA and Cash Position of €2.8m | 20103010 Biotechnology | Sales |
18 Jul 2024 18:30 CEST |
SARTORIUS STEDIM BIOTECH | Half-year results 2024 of SartoriusStedimBiotech | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:30 CEST |
SARTORIUS STEDIM BIOTECH | Résultats de Sartorius Stedim Biotech pour le premier semestre 2024 | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:30 CEST |
ADVICENNE | Advicenne Announces an 8.8% Increase in Gross Sales for H1 2024 and Provides an Update on Its Activities | 20103010 Biotechnology | Sales |
18 Jul 2024 18:30 CEST |
ADVICENNE | Advicenne annonce une progression de 8,8% des ventes brutes au S1 2024 et fait le point sur ses activités | 20103010 Biotechnology | Sales |
18 Jul 2024 18:28 CEST |
FORSEE POWER | Forsee Power publie son 5ème rapport de développement durableet l’intégralité de son empreinte carbone | 50202010 Electrical Components | Corporate life |
18 Jul 2024 18:28 CEST |
FORSEE POWER | Forsee Power Publishes its 5th Sustainability Report and Its Complete Carbon Footprint | 50202010 Electrical Components | Corporate life |
18 Jul 2024 18:21 CEST |
SARTORIUS STEDIM BIOTECH | Sartorius Stedim Biotech SA: Sartorius Stedim Biotech ajuste ses prévisions pour l’exercice 2024 et présente ses résultats pur le premier semestre 2024 | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:21 CEST |
SARTORIUS STEDIM BIOTECH | Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024 | 20102015 Medical Supplies | Commercial results |
18 Jul 2024 18:17 CEST |
VRANKEN-POMMERY | VRANKEN-POMMERY MONOPOLE - CHIFFRE D'AFFAIRES DU 1ER SEMESTRE 2024 : Chiffre d’affaires de 108 M€ (-5,8%) Premier semestre préservé dans un marché en baisse | 45101015 Distillers and Vintners | Share history |
18 Jul 2024 18:17 CEST |
VRANKEN-POMMERY | Vranken-Pommery Monopole - 2024 First-Half Turnover- Consolidated turnover € 108 million (-5,8%) First half on track in a declining market | 45101015 Distillers and Vintners | Share history |
18 Jul 2024 18:06 CEST |
SHELL PLC | Transaction in Own Shares | 60101000 Integrated Oil and Gas | Other subject |
18 Jul 2024 18:00 CEST |
BIOSYNEX | BIOSYNEX SA: CA DU S1 2024 EN CROISSANCE : 53,8 M€ (+26% DONT +6% ORGANIQUE) - FORTE CONTRIBUTION DES ACQUISITIONS ET MONTEE EN PUISSANCE DES FILIALES AMERICAINES | 20102010 Medical Equipment | Sales |
18 Jul 2024 18:00 CEST |
I2S | i2S : Chiffre d\'affaires S1 2024 | 50202025 Electronic Equipment: Gauges and Meters | General meeting / Board Meeting |
18 Jul 2024 18:00 CEST |
ACTICOR BIOTECH | Acticor Biotech: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux | 20103010 Biotechnology | Other subject |
18 Jul 2024 18:00 CEST |
HIGH CO | HighCo: Q2 2024 Gross Profit | 40301020 Media Agencies | Sales |
18 Jul 2024 18:00 CEST |
AIR FRANCE -KLM | Air France-KLM et Air France annoncent avoir renégocié avec succès leur ligne de crédit renouvelable liée au développement durable, portée à 1,4 milliard d’euros, avec une extension de son échéance à juillet 2028 | 40501010 Airlines | Other subject |